PPARG and breast carcinoma: Furthermore, ERK1/2 can target and activate several nuclear receptors, e.g., estrogen receptor (ER), a receptor upregulated in breast cancer [76,77], or peroxisome proliferator-activated receptor gamma (PPARγ), a receptor involved in diabetes and obesity [78].